Levodopa for the Treatment of Parkinson's Disease.

被引:205
作者
LeWitt, Peter A. [1 ,2 ]
机构
[1] Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA
[2] Wayne State Univ, Dept Neurol, Detroit, MI USA
关键词
D O I
10.1056/NEJMct0800326
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:2468 / 2476
页数:9
相关论文
共 55 条
[1]   Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature [J].
Ahlskog, JE ;
Muenter, MD .
MOVEMENT DISORDERS, 2001, 16 (03) :448-458
[2]   Dementia and survival in Parkinson disease - A 12-year population study [J].
Buter, T. C. ;
van den Hout, A. ;
Matthews, F. E. ;
Larsen, J. P. ;
Brayne, C. ;
Aarsland, D. .
NEUROLOGY, 2008, 70 (13) :1017-1022
[3]   AMOUNT AND DISTRIBUTION OF DIETARY-PROTEIN AFFECTS CLINICAL-RESPONSE TO LEVODOPA IN PARKINSONS-DISEASE [J].
CARTER, JH ;
NUTT, JG ;
WOODWARD, WR ;
HATCHER, LF ;
TROTMAN, TL .
NEUROLOGY, 1989, 39 (04) :552-556
[4]   Levodopa slows progression of Parkinson's disease. External validation by clinical trial simulation [J].
Chan, Phylinda L. S. ;
Nutt, John G. ;
Holford, Nicholas H. G. .
PHARMACEUTICAL RESEARCH, 2007, 24 (04) :791-802
[5]   MODIFICATION OF PARKINSONISM - CHRONIC TREATMENT WITH L-DOPA [J].
COTZIAS, GC ;
PAPAVASI.PS ;
GELLENE, R .
NEW ENGLAND JOURNAL OF MEDICINE, 1969, 280 (07) :337-&
[6]   VERTEILUNG VON NORADRENALIN UND DOPAMIN (3-HYDROXYTYRAMIN) IM GEHIRN DES MENSCHEN UND IHR VERHALTEN BEI ERKRANKUNGEN DES EXTRAPYRAMIDALEN SYSTEMS [J].
EHRINGER, H ;
HORNYKIEWICZ, O .
KLINISCHE WOCHENSCHRIFT, 1960, 38 (24) :1236-1239
[7]  
Fahn S, 2004, NEW ENGL J MED, V351, P2498
[8]   Update on the genetics of Parkinson's disease [J].
Gasser, Thomas .
MOVEMENT DISORDERS, 2007, 22 :S343-S350
[9]   Evidence-based medical review update: Pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004 [J].
Goetz, CG ;
Poewe, W ;
Rascol, O ;
Sampaio, C .
MOVEMENT DISORDERS, 2005, 20 (05) :523-539
[10]  
GOETZ CG, 2002, MOV DISORD S4, V17, pS1